Kevin Brennan - 30 Mar 2023 Form 3 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role: SVP, FINANCE AND ACCOUNTING
Signature: /s/ Julia Walcott, Attorney-in-Fact
Issuer symbol: XLO
Transactions as of: 30 Mar 2023
Transactions value $: $0
Form type: 3
Filing time: 03 Apr 2023, 16:07:40
Next filing: 03 Apr 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney